Related Experiment Video
Updated: Jul 13, 2026

Pipeline for Multi-Scale Three-Dimensional Anatomic Study of the Human Heart
Published on: June 28, 2024
Essential PTX3 biology (not only) for cardiologists and cardiac surgeons
Pavel Kunes1, Vladimír Lonský, Jirí Mand'ák
1Charles University in Prague, Faculty of Medicine in Hradec Králové, Department of Cardiac Surgery, Czech Republic. kunes.pavel@fnhk.cz
Insights
Inflammation is key in atherosclerosis. Pentraxin 3 (PTX3), an acute phase reactant, may actively mediate cardiovascular diseases and wound healing, impacting innate immunity.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
- Surgery
Background:
- Inflammation is integral to atherosclerosis.
- C-reactive protein (CRP) is a known mediator.
- Pentraxin 3 (PTX3) is a newly identified acute phase reactant.
Purpose of the Study:
- To review PTX3 biology in inflammation and innate immunity.
- To discuss PTX3's role in cardiovascular disease from a cardiologist's view.
- To examine PTX3's role in wound healing and infection from a surgeon's view.
Main Methods:
- Literature review of recent scientific information.
- Analysis of PTX3's structural and functional properties.
- Comparison of PTX3 with CRP.
Main Results:
- PTX3 shares properties with CRP but has unique biological functions.
- PTX3 may play a role in cardiovascular disease pathogenesis.
- PTX3 is involved in processes accompanying surgical wound healing and bacterial infections.
Conclusions:
- PTX3 is a significant factor in inflammation and innate immunity.
- PTX3's role in cardiovascular events and surgical complications warrants further investigation.
- Understanding PTX3 biology offers insights for both cardiology and surgery.
Abstract:
Inflammation has been recognized to form an integral part of the atherosclerotic process. Much consideration has been given lately to the role played in atherogenesis by C-reactive protein (CRP). Although not accepted unequivocally, CRP appears to be not only a marker, but also an active mediator of the atherosclerotic process. Pentraxin 3 (PTX3) is a newly identified acute phase reactant which shares some structural and some functional properties with CRP. On the other hand, pentraxin 3 displays unique biological properties of its own, including a possible role in the pathogenesis of cardiovascular diseases and in processes accompanying the natural evolution of surgical wounds. This review article discusses recent information concerning basic pentraxin 3 biology in inflammation and in innate immunity reactions as viewed by a cardiologist in the context of acute coronary events and by a surgeon in patients struck with multiple wounds who are at the same time menaced by bacterial infections.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization III: Left Heart Catheterization
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

